Like the broader equity market, healthcare stocks experienced bouts of volatility during the third quarter. But attractive valuations, continued innovation and an uptick in merger and acquisitions could help lift the sector, says Portfolio Manager Andy Acker.
- Like the broader equity market, healthcare stocks experienced volatility during the third quarter, though for sector-specific reasons.
- In particular, a sharp pullback in small- and mid-cap biotech stocks that started in February continued through mid-August.
- However, low valuations and continued innovation have led to an uptick in mergers and acquisitions, which could help support the sector. In addition, other headwinds could prove transitory.
Price-to-earnings (P/E) ratio – measures share price compared to earnings per share for a stock or stocks in a portfolio.
Volatility – The rate and extent at which the price of a portfolio, security or index, moves up and down. If the price swings up and down with large movements, it has high volatility.